P6237Clinical utility of echocardiographic left-ventricular ejection fraction monitoring for cardiotoxicity risk assessment in patients with HER2+ early breast cancer undergoing trastuzumab-based therapy
Posch, F, Glantschnig, T, Firla, S, Smolle, M, Balic, M, Moik, F, Stoeger, H, Zirlik, A, Pichler, M, Rainer, P
Published in European heart journal (01.10.2019)
Published in European heart journal (01.10.2019)
Get full text
Journal Article